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Itching for Explanations
Considering that with the exception of impairment of image, itch is
the main symptom of skin disease, it remains woefully neglected:
serious science seems to take over from relevance! Another curious
aspect of itch research is that the ®eld does not seem to be as
popular as it was 20y ago. Things may however, be changing.
Recently there have been signi®cant insights into the neuro-
physiology of itching, with clear evidence for a distinct class of
small ®ber C-®bres transmitting itch, and, as the paper by Andoh
and colleagues (p. 1621) shows, the pharmacology of itch is
becoming less opaque
The clinical problem with itching can be simply stated: while there
are highly effective and selective H1 antagonists it would appear that
much clinically relevant itching is not mediated by histamine. The
research question is therefore what are the other physiologic and
pathologic mediators of itch are there one or many.
In this study in mice, using injection of substance P and a variety
of pharmacologic inhibitors, Andoh and colleagues show that
substance P-induced scratching appears to be an itch-associated
response. They highlight a potential important role for the
arachidonic cascade in substance P-induced itching. A leukotriene
B4 (LTB4) receptor antagonist markedly suppressed substance P
itch-induced scratching. The ®ndings, the authors argue, suggest
that LTB4 is involved in substance P-induced itching at least in
mice and they suggest that LTB4 receptor and 5-lipoxygenase
receptor antagonists might be potentially useful antipruritic
drugs.
What of prostaglandins and cyclooxygenase inhibition? This
work, in keeping with previous work in man, suggests that they
may not be critical at least not in this assay system. Whilst evidence
of the ability of prostaglandins to potentate itching is available, in
the current system other pathways seem to be more appropriate.
Future work needs to explore how far these explanations hold true
in man.
Teeth, Nails, Feet, and Bootstraps
Baron Von Munschhausen, deep underwater, was reputed to have
pulled himself up by using his bootlaces, hence the phrase
bootstrap. It is one of the most curious aspects of science, having
to explain to nonscientists that science makes use of inadequate
explanations at least inadequate as de®ned by future generations all
the time. The mapping of genodermatoses provides many such
pertinent examples.
Without a clinical syndrome you cannot de®ne a pedigree, and
hence you cannot carry out positional cloning. But, until you have
a gene, your description of the syndrome is by de®nition dif®cult to
de®ne in cellular or genetic terms. Once, however, you have the
gene, the bootstrap allows you to go back to your clinical
description and perhaps improve it or even change it signi®cantly.
Pachyonychia congenita is an autosomal dominantly inherited
group of ectodermal dysplasias with a wide variety of clinical
features, including nail dystrophy, palmoplantar hyperkeratosis, and
cysts. Clinical heterogeneity has long been known and distinct
syndromes suspected. Over the last few years those interested in
keratin genetics have revealed that pachyonychia congenita can
arise due to mutations in keratin 6a, keratin 16, and keratin 17. A
natural question is to ask what relation there is between genotype
and phenotype.
Terrinoni et al (p. 1391) have studied 13 kindreds with this rare
condition and attempted to relate the presence of pilosebaceous
cysts and other clinical features to the gene defect. Their
conclusions are that pilosebaceous cysts (after puberty) are the best
indicators of pachyonychia congenita type 2 (PC2) and that natal
teeth are also indicative of this syndrome. They argue that
mutations of keratin 6a or keratin 16 produce PC1, whereas
keratin 17 (or keratin 6b) mutations cause PC2.
In a further bootstrap, however, once you accept that
pachyonychia congenita is caused by certain keratin mutations,
researchers start chasing those instances where mutations are not
found. The current authors, following their comprehensive
screening of the known genes, argue that there may be cases of
pachyonychia where other genes may well be involved. The
structure of the keratin clusters means that simple mapping may not
answer this question as easily as one might have hoped.
Ultraviolet, and More Ultraviolet . . .
Many papers in this issue are concerned with the relation between
ultraviolet radiation and human skin physiology and patho-
physiology. It would seem that ultraviolet radiation is active in
virtually any assay system you throw it at. We know from previous
work published in this journal that ultraviolet radiation has effects
on DNA, on proteins and messenger RNA, and also on cell
membranes. Ultraviolet seems to effect keratinocytes, Langerhans
cells, melanocytes, and so on. All very complex.
One requirement, long overdue, is a better quantitative under-
standing of the effects of ultraviolet radiation on these various
pathways. It is no longer helpful just to document an in¯uence, we
need to somehow integrate this knowledge in a more systems-based
approach. Within this general theme one question of great interest
to skin biologists is whether variation in dose seen at one level of
explanation, such as individual cells, can be meaningfully related to
variation in dose seen at another level of explanation, such as
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irradiation of intact skin in the whole person. Does intermittent
exposure in cell culture re¯ect the intermittent exposure implicated
in melanoma pathogenesis? Are the apoptotic cells studied in
keratinocytes on plastic relevant to events in intact skin, and is the
numerical balance between inhibition of cell cycle and apoptosis
the same in these different contexts.
The paper by Maeda et al (p. 1490) casts light on at least one
interesting area. The authors, studying human keratinocytes in
culture, looked at the effects of ultraviolet B radiation on expression
and activity of nucleotide excision repair genes. They used RNase
protection assays and slot blot DNA repair activity assays. They
report that whilst cyclobutane pyrimidine dimers were removed
ef®ciently after exposure to low doses of ultraviolet radiation B, this
activity was delayed signi®cantly at higher doses. They suggested
that their data support the notion that nucleotide excision repair is
inducible in cells exposed to low doses which we assume would
protect keratinocytes from cell death but by contrast, exposure to
higher doses downregulates nucleotide excision repair and is
associated with cell death.
This dose or context dependency of cellular behavior, is going to
be confusing to incorporate into models of the effects of ultraviolet
radiation on intact skin. How researchers are going to take this
complexity on board, and circumvent it, remains to be seen.
Psoriasis and Cancer
It has long been of great biologic interest as to why a disease
characterized by rampant hyperproliferation (exceeding that seen in
many neoplasms) and prominent in¯ammation, does not predispose
more often to cancer. The puzzle still remains.
Boffetta et al (p. 1531) examined cancer rates in people with
psoriasis who had been treated as in-patients in Sweden. The major
strength of this paper is that it relies on the excellent record linkage
capabilities of the Swedish healthcare system: few regions of the
world are able to compete.
Boffetta et al looked at the incidence of cancer in a cohort of
almost 10000 patients with psoriasis who were hospitalized
between 1965 and 1983. They used the Swedish National Board
of Health and Welfare In-patient Register, and linked this to the
Swedish Cancer Register. They ®nd a modest increase in the risk of
some malignancies including those of the oral cavity, liver,
pancreas, lung, and breast, while others, such as those of the penis
and vulva, show higher risk ratios. They also report an increased
risk of nonmelanoma skin cancer.
As they suggest, some of their results could be explained by
differences in smoking behavior between patients with psoriasis and
the general population many of the tumors are associated with
tobacco use. This should serve to remind all that those with a
disease can be different than those without a disease in many ways
confounding remains a tricky methodologic problem more
troublesome than accounting for random error.
Of great interest is that the rate of melanoma was not only not
increased in these individuals, but was signi®cantly reduced. There
may be limitations to their conclusions in this respect, depending as
they do on sample size and what other treatments the patients had had
during this long period of time. Treatments have changed, and the use
of phototherapy and PUVA in particular has increased. Nonetheless
their observations challenge over-simplistic interpretations of the
relation between therapeutically administered ultraviolet radiation,
and the psoriatic state, and carcinogenesis. Future more in-depth and
detailed study of some of these individuals, and further progress
reports on this cohort, will be awaited with great interest.
Melanin, Hemoglobin, and Light Scattering
Understanding the skins response to ultraviolet radiation serves to
remind us of the limitations of, and subservience of cellular
molecular biology to, physiology. This response is a characteristic
of the organ, where physics may be as important as biology. One
issue that confronts those who wish to study such areas has been the
dif®culty in distinguishing between changes in blood ¯ow and
changes in pigmentation. This problem still remains; and whereas
use of re¯ectance instruments in the early period following
ultraviolet radiation may be valid, beyond the ®rst few days their
use is unsatisfactory. Zonios and colleagues (p. 1452) report in vivo
measurements of diffuse re¯ectance spectra in the visible and near
infrared ranges of the electromagnetic spectrum. Using an analytical
model of diffusion in the skin the authors suggest that it may well
be possible to distinguish quantitatively between hemoglobin and
melanin content.
These conclusions promise a considerable advance in our ability
to describe and objectify different phototypes. What is now
required is further validation based on in vivo experiments with
other measures of photoprotection to see how accurately the model
can predict blood ¯ow and photoprotection when independently
ascertained.
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